Steward Partners Investment Advisory’s LumiraDx Limited Warrant LMDXW Stock Holding History

Steward Partners Investment Advisory’s Portfolio LMDXW Stock Details LMDXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21	Closed	–	–	3762
2024 Q1	$0	Hold	21	–	–	﹤0.01%	3712
2023 Q4	$0	Hold	21	–	–	﹤0.01%	3604
2023 Q3	$1	Buy	+21	New	+$1	﹤0.01%	3377

Other funds holding LMDXW

CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Steward Partners Investment Advisory's LMDXW Position: Q2 2024 in Review

Steward Partners Investment Advisory sold out of LumiraDx Limited Warrant (LMDXW) in Q2 2024, closing a stake of 21 shares.

Steward Partners Investment Advisory first reported a position in LMDXW in Q3 2023 and held it in 3 quarters. The position peaked at $1 in Q3 2023. 2 funds tracked by Wall St. Rank hold LMDXW as of Q2 2024.

Steward Partners Investment Advisory reported no remaining LumiraDx Limited Warrant position as of Q2 2024 after selling out during the quarter.
Steward Partners Investment Advisory sold 21 LumiraDx Limited Warrant shares in Q2 2024.
Steward Partners Investment Advisory first reported a position in LumiraDx Limited Warrant in Q3 2023 and held it in 3 quarters.
Steward Partners Investment Advisory's LumiraDx Limited Warrant position peaked at $1 in Q3 2023.
2 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q2 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2024, filed 8 Aug 2024.